Fluicell (Sweden) Insiders
| FLUI Stock | SEK 10.00 0.70 6.54% |
Fluicell employs about 19 people. The company is managed by 6 executives with a total tenure of roughly 45 years, averaging almost 7.0 years of service per executive, having 3.17 employees per reported executive. Breaking down Fluicell's management performance can provide insight into the firm performance.
| Matija Rojnik Insider Chief Officer |
| Tatsiana Lobovkina Insider Chief Officer |
Fluicell |
Fluicell Management Team Effectiveness
The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1298) %, meaning that it generated substantial loss on money invested by shareholders. Fluicell's management efficiency ratios could be used to measure how well Fluicell manages its routine affairs as well as how well it operates its assets and liabilities.Fluicell holds a total of 24.49 Million outstanding shares. Fluicell AB shows 11.2 percent of its outstanding shares held by insiders and 0.67 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Fluicell Workforce Comparison
Fluicell AB is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 66.0. Fluicell totals roughly 19.0 in number of employees claiming about 29% of stocks in Biotechnology industry.
Fluicell AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Fluicell AB Price Series Summation is a cross summation of Fluicell price series and its benchmark/peer.
Fluicell Notable Stakeholders
A Fluicell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fluicell often face trade-offs trying to please all of them. Fluicell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fluicell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Matija Rojnik | Chief Officer | Profile | |
| Tatsiana Lobovkina | Chief Officer | Profile | |
| Mats Jonasson | Chief Officer | Profile | |
| Victoire Viannay | Chief Officer | Profile | |
| Jonas Hannestad | Chief Officer | Profile | |
| Gavin Jeffries | CTO Director | Profile |
About Fluicell Management Performance
The success or failure of an entity such as Fluicell AB often depends on how effective the management is. Fluicell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fluicell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fluicell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company was founded in 2012 and is based in Gothenburg, Sweden. Fluicell operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.
Please note, the imprecision that can be found in Fluicell's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fluicell AB. Check Fluicell's Beneish M Score to see the likelihood of Fluicell's management manipulating its earnings.
Fluicell Workforce Analysis
Traditionally, organizations such as Fluicell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fluicell within its industry.Fluicell Manpower Efficiency
Return on Fluicell Manpower
| Revenue Per Employee | 136.9K | |
| Revenue Per Executive | 433.7K | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 3.6M |
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.